In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine

Supplemental Digital Content is available in the text.

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 144; no. 6; pp. 487 - 498
Main Authors Muthukumar, Alagarraju, Narasimhan, Madhusudhanan, Li, Quan-Zhen, Mahimainathan, Lenin, Hitto, Imran, Fuda, Franklin, Batra, Kiran, Jiang, Xuan, Zhu, Chengsong, Schoggins, John, Cutrell, James B., Croft, Carol L., Khera, Amit, Drazner, Mark H., Grodin, Justin L., Greenberg, Benjamin M., Mammen, Pradeep P.A., Morrison, Sean J., de Lemos, James A.
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 10.08.2021
Subjects
2019-nCoV Vaccine mRNA-1273
Cases and Traces
COVID-19 - blood
COVID-19 - immunology
COVID-19 - physiopathology
COVID-19 - prevention & control
COVID-19 Vaccines - administration & dosage
COVID-19 Vaccines - adverse effects
Humans
Immunization, Secondary - adverse effects
Male
Middle Aged
Myocarditis - blood
Myocarditis - chemically induced
Myocarditis - diagnostic imaging
Myocarditis - physiopathology
SARS-CoV-2 - immunology
SARS-CoV-2 - metabolism
COVID-19
COVID-19 vaccine
vaccine
myocarditis
Online AccessGet full text

Cover

More Information
Summary:Supplemental Digital Content is available in the text.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-5
ObjectType-Undefined-3
ObjectType-Article-4
ObjectType-Report-1
ISSN:0009-7322
1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.121.056038